OpenVSafe by OpenVAERS
Search V-safe

A5S-23572-88401

3 vaccinations 2 coded responses 37 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
554 / MN
Registered
2021-03-29
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-29
    Registered in v-safe
  2. 2021-03-29
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-29
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-03-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-03-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-04-01
    Survey response — days 1–6 daily, dose 1
    MedDRA: Eye pruritus, Lacrimation increased — Feeling: Fair
    Free text: Itchy water eyes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-04-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache, Muscle or body aches
    Adult check-in
  8. 2021-04-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-05
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-04-12
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-04-19
    Dose 2 — Pfizer-BioNTech
  13. 2021-04-19
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · None
    Adult check-in
  14. 2021-04-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  15. 2021-04-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  16. 2021-04-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-04-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-04-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-04-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-04-26
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-05-03
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-10
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-05-17
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-05-24
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-05-31
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-07-19
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-10-18
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-11-07
    Dose 3 — Pfizer-BioNTech
  29. 2021-11-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  30. 2021-11-11
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  31. 2021-11-12
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  32. 2021-11-13
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  33. 2021-11-16
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  34. 2021-11-21
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  35. 2021-11-28
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  36. 2021-12-05
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  37. 2021-12-12
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-12-19
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  39. 2022-02-06
    Survey response — 3 months, dose 3
    MedDRA: Abortion spontaneous — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Miscarriage
    MedDRA releases: 2024-11 · check-in free text available
  40. 2022-02-06
    Report sent to call center — 3 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  41. 2022-03-31
  42. 2022-05-08
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  43. 2022-11-07
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-29Pfizer-BioNTech
22021-04-19Pfizer-BioNTech
32021-11-07Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-02-06 Unsuccessful

Free text

Release 6 — days 1–6 daily, dose 1

2021-04-01

Systemic reaction (other): Itchy water eyes

Release 11 — 3 months, dose 3

2022-02-06

Symptoms: Miscarriage

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbortion spontaneous · · ✓
SROEye pruritus ✓ ✓ ✓
SROLacrimation increased ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…